Metastasis-directed thermal ablation in patients with metastatic breast cancer and visceral oligoprogression or oligopersistence: a cohort study
Selected patients with visceral oligoprogressive and oligopersistent mBC appear to benefit from TA and systemic treatment continuation or modulation. This strategy can be implemented for selected patients in the framework of a multidisciplinary tumor board's shared decision.
Authors
- Giuseppe Curigliano (ORCID: https://orcid.org/0000-0003-1781-2518)
- Daniele Maiettini (ORCID: https://orcid.org/0000-0003-4421-7941)
- Franco Orsi (ORCID: https://orcid.org/0000-0002-7330-0499)
- Gianluca Maria Varano (ORCID: https://orcid.org/0000-0003-4505-5841)
- Guido Bonomo (ORCID: https://orcid.org/0000-0001-8584-009X)
- Dario Trapani (ORCID: https://orcid.org/0000-0003-1672-9560)
- Elisabetta Munzone (ORCID: https://orcid.org/0000-0003-3371-3878)
- Nadia Bianco (ORCID: https://orcid.org/0000-0001-5765-7765)
- Marco Colleoni (ORCID: https://orcid.org/0000-0002-5743-3013)
- Claudia Sangalli (ORCID: https://orcid.org/0000-0002-6465-0630)
- Paolo Della Vigna (ORCID: https://orcid.org/0000-0002-8523-9226)
- Carmine Valenza (ORCID: https://orcid.org/0000-0003-1150-0345)
- Monica Milano (ORCID: https://orcid.org/0000-0003-0983-1604)
- Maria Giovanna Pitoni
- Elena Battaiotto
- Matteo Cavallone
- Roberta Multinu
- Giulia Malvezzi
Institutions
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- European Institute of Oncology (IT)
Publication Details
- Journal
- The Breast
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1016/j.breast.2025.104667
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00